EU-Startups
Irish BioTech Aerska launches with €17 million to develop RNAi medicines for diseases of the brain
Aerska, a Dublin-based BioTech company aiming to redefine the treatment of neurological diseases, today announced it has raised €17 million in Seed financing to develop systemically […]
